Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study

This study investigates the association between epigenetic age acceleration (EAA) derived from DNA methylation and the risk of incident colorectal cancer (CRC). We utilized data from a random population sample of 9,360 individuals (men and women, aged 45-69) from the HAPIEE Study who had been follow...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024-05, Vol.25 (9), p.4850
Hauptverfasser: Malyutina, Sofia, Chervova, Olga, Maximov, Vladimir, Nikitenko, Tatiana, Ryabikov, Andrew, Voevoda, Mikhail
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 9
container_start_page 4850
container_title International journal of molecular sciences
container_volume 25
creator Malyutina, Sofia
Chervova, Olga
Maximov, Vladimir
Nikitenko, Tatiana
Ryabikov, Andrew
Voevoda, Mikhail
description This study investigates the association between epigenetic age acceleration (EAA) derived from DNA methylation and the risk of incident colorectal cancer (CRC). We utilized data from a random population sample of 9,360 individuals (men and women, aged 45-69) from the HAPIEE Study who had been followed up for 16 years. A nested case-control design yielded 35 incident CRC cases and 354 matched controls. Six baseline epigenetic age (EA) measures (Horvath, Hannum, PhenoAge, Skin and Blood (SB), BLUP, and Elastic Net (EN)) were calculated along with their respective EAAs. After adjustment, the odds ratios (ORs) for CRC risk per decile increase in EAA ranged from 1.20 (95% CI: 1.04-1.39) to 1.44 (95% CI: 1.21-1.76) for the Horvath, Hannum, PhenoAge, and BLUP measures. Conversely, the SB and EN EAA measures showed borderline inverse associations with ORs of 0.86-0.87 (95% CI: 0.76-0.99). Tertile analysis reinforced a positive association between CRC risk and four EAA measures (Horvath, Hannum, PhenoAge, and BLUP) and a modest inverse relationship with EN EAA. Our findings from a prospective population-based-case-control study indicate a direct association between incident CRC and four markers of accelerated baseline epigenetic age. In contrast, two markers showed a negative association or no association. These results warrant further exploration in larger cohorts and may have implications for CRC risk assessment and prevention.
doi_str_mv 10.3390/ijms25094850
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3053977756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A793566705</galeid><sourcerecordid>A793566705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-1b12dc94bbd2bb332ded8d2e0f7245d642ee621e1a02f85ba7730dbdd997b3dc3</originalsourceid><addsrcrecordid>eNptkUtv1DAUhS0Eou3AjjWyxIZFU_xI4pjdNGpLpUpFPNaRHzcjD4492M6iO35603aAUqEr-VrWd8691kHoDSUnnEvywW2nzBoi664hz9AhrRmrCGnF80f3A3SU85YQxlkjX6ID3gnOSCsP0a9TH6OtTlUGi892bgMBijN4vQG8NgY8JFVcDFgFiy-DcRZCwX30MYEpyuNeBQMJf3H5x0d87oJ1YZPxmOKEFf4cd7O_1-8n9MtZ9TGUFD3-WmZ78wq9GJXP8HrfV-j7-dm3_lN1dX1x2a-vKsM7WiqqKbNG1lpbpjXnzILtLAMyClY3tq0ZQMsoUEXY2DVaCcGJ1dZKKTS3hq_Q-wffXYo_Z8hlmFxe_udVgDjngZOGSyFE0y7ouyfoNs4pLNvdU1S0Ha__UhvlYXBhjCUpc2c6rIXkTduKBV6hk_9QS1mYnIkBRre8_yM4fhCYFHNOMA675CaVbgZKhrvAh8eBL_jb_a6znsD-gX8nzG8BxrylYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3053176834</pqid></control><display><type>article</type><title>Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study</title><source>MEDLINE</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Malyutina, Sofia ; Chervova, Olga ; Maximov, Vladimir ; Nikitenko, Tatiana ; Ryabikov, Andrew ; Voevoda, Mikhail</creator><creatorcontrib>Malyutina, Sofia ; Chervova, Olga ; Maximov, Vladimir ; Nikitenko, Tatiana ; Ryabikov, Andrew ; Voevoda, Mikhail</creatorcontrib><description>This study investigates the association between epigenetic age acceleration (EAA) derived from DNA methylation and the risk of incident colorectal cancer (CRC). We utilized data from a random population sample of 9,360 individuals (men and women, aged 45-69) from the HAPIEE Study who had been followed up for 16 years. A nested case-control design yielded 35 incident CRC cases and 354 matched controls. Six baseline epigenetic age (EA) measures (Horvath, Hannum, PhenoAge, Skin and Blood (SB), BLUP, and Elastic Net (EN)) were calculated along with their respective EAAs. After adjustment, the odds ratios (ORs) for CRC risk per decile increase in EAA ranged from 1.20 (95% CI: 1.04-1.39) to 1.44 (95% CI: 1.21-1.76) for the Horvath, Hannum, PhenoAge, and BLUP measures. Conversely, the SB and EN EAA measures showed borderline inverse associations with ORs of 0.86-0.87 (95% CI: 0.76-0.99). Tertile analysis reinforced a positive association between CRC risk and four EAA measures (Horvath, Hannum, PhenoAge, and BLUP) and a modest inverse relationship with EN EAA. Our findings from a prospective population-based-case-control study indicate a direct association between incident CRC and four markers of accelerated baseline epigenetic age. In contrast, two markers showed a negative association or no association. These results warrant further exploration in larger cohorts and may have implications for CRC risk assessment and prevention.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25094850</identifier><identifier>PMID: 38732069</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age ; Aged ; Aging ; Alcohol use ; Biotechnology industry ; Cancer ; Case-Control Studies ; Colorectal cancer ; Colorectal Neoplasms - epidemiology ; Colorectal Neoplasms - genetics ; DNA Methylation ; Epigenesis, Genetic ; Epigenetic inheritance ; Epigenetics ; Female ; Humans ; Incidence ; Male ; Methylation ; Middle Aged ; Mitochondrial DNA ; Mortality ; Mutation ; Oncology, Experimental ; Risk Factors ; Skin ; Sulindac ; Women</subject><ispartof>International journal of molecular sciences, 2024-05, Vol.25 (9), p.4850</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c381t-1b12dc94bbd2bb332ded8d2e0f7245d642ee621e1a02f85ba7730dbdd997b3dc3</cites><orcidid>0000-0001-9425-413X ; 0000-0002-1671-9488 ; 0000-0002-7165-4496</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38732069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malyutina, Sofia</creatorcontrib><creatorcontrib>Chervova, Olga</creatorcontrib><creatorcontrib>Maximov, Vladimir</creatorcontrib><creatorcontrib>Nikitenko, Tatiana</creatorcontrib><creatorcontrib>Ryabikov, Andrew</creatorcontrib><creatorcontrib>Voevoda, Mikhail</creatorcontrib><title>Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>This study investigates the association between epigenetic age acceleration (EAA) derived from DNA methylation and the risk of incident colorectal cancer (CRC). We utilized data from a random population sample of 9,360 individuals (men and women, aged 45-69) from the HAPIEE Study who had been followed up for 16 years. A nested case-control design yielded 35 incident CRC cases and 354 matched controls. Six baseline epigenetic age (EA) measures (Horvath, Hannum, PhenoAge, Skin and Blood (SB), BLUP, and Elastic Net (EN)) were calculated along with their respective EAAs. After adjustment, the odds ratios (ORs) for CRC risk per decile increase in EAA ranged from 1.20 (95% CI: 1.04-1.39) to 1.44 (95% CI: 1.21-1.76) for the Horvath, Hannum, PhenoAge, and BLUP measures. Conversely, the SB and EN EAA measures showed borderline inverse associations with ORs of 0.86-0.87 (95% CI: 0.76-0.99). Tertile analysis reinforced a positive association between CRC risk and four EAA measures (Horvath, Hannum, PhenoAge, and BLUP) and a modest inverse relationship with EN EAA. Our findings from a prospective population-based-case-control study indicate a direct association between incident CRC and four markers of accelerated baseline epigenetic age. In contrast, two markers showed a negative association or no association. These results warrant further exploration in larger cohorts and may have implications for CRC risk assessment and prevention.</description><subject>Age</subject><subject>Aged</subject><subject>Aging</subject><subject>Alcohol use</subject><subject>Biotechnology industry</subject><subject>Cancer</subject><subject>Case-Control Studies</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - epidemiology</subject><subject>Colorectal Neoplasms - genetics</subject><subject>DNA Methylation</subject><subject>Epigenesis, Genetic</subject><subject>Epigenetic inheritance</subject><subject>Epigenetics</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Methylation</subject><subject>Middle Aged</subject><subject>Mitochondrial DNA</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Oncology, Experimental</subject><subject>Risk Factors</subject><subject>Skin</subject><subject>Sulindac</subject><subject>Women</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkUtv1DAUhS0Eou3AjjWyxIZFU_xI4pjdNGpLpUpFPNaRHzcjD4492M6iO35603aAUqEr-VrWd8691kHoDSUnnEvywW2nzBoi664hz9AhrRmrCGnF80f3A3SU85YQxlkjX6ID3gnOSCsP0a9TH6OtTlUGi892bgMBijN4vQG8NgY8JFVcDFgFiy-DcRZCwX30MYEpyuNeBQMJf3H5x0d87oJ1YZPxmOKEFf4cd7O_1-8n9MtZ9TGUFD3-WmZ78wq9GJXP8HrfV-j7-dm3_lN1dX1x2a-vKsM7WiqqKbNG1lpbpjXnzILtLAMyClY3tq0ZQMsoUEXY2DVaCcGJ1dZKKTS3hq_Q-wffXYo_Z8hlmFxe_udVgDjngZOGSyFE0y7ouyfoNs4pLNvdU1S0Ha__UhvlYXBhjCUpc2c6rIXkTduKBV6hk_9QS1mYnIkBRre8_yM4fhCYFHNOMA675CaVbgZKhrvAh8eBL_jb_a6znsD-gX8nzG8BxrylYA</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Malyutina, Sofia</creator><creator>Chervova, Olga</creator><creator>Maximov, Vladimir</creator><creator>Nikitenko, Tatiana</creator><creator>Ryabikov, Andrew</creator><creator>Voevoda, Mikhail</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9425-413X</orcidid><orcidid>https://orcid.org/0000-0002-1671-9488</orcidid><orcidid>https://orcid.org/0000-0002-7165-4496</orcidid></search><sort><creationdate>20240501</creationdate><title>Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study</title><author>Malyutina, Sofia ; Chervova, Olga ; Maximov, Vladimir ; Nikitenko, Tatiana ; Ryabikov, Andrew ; Voevoda, Mikhail</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-1b12dc94bbd2bb332ded8d2e0f7245d642ee621e1a02f85ba7730dbdd997b3dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Aged</topic><topic>Aging</topic><topic>Alcohol use</topic><topic>Biotechnology industry</topic><topic>Cancer</topic><topic>Case-Control Studies</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - epidemiology</topic><topic>Colorectal Neoplasms - genetics</topic><topic>DNA Methylation</topic><topic>Epigenesis, Genetic</topic><topic>Epigenetic inheritance</topic><topic>Epigenetics</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Methylation</topic><topic>Middle Aged</topic><topic>Mitochondrial DNA</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Oncology, Experimental</topic><topic>Risk Factors</topic><topic>Skin</topic><topic>Sulindac</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malyutina, Sofia</creatorcontrib><creatorcontrib>Chervova, Olga</creatorcontrib><creatorcontrib>Maximov, Vladimir</creatorcontrib><creatorcontrib>Nikitenko, Tatiana</creatorcontrib><creatorcontrib>Ryabikov, Andrew</creatorcontrib><creatorcontrib>Voevoda, Mikhail</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malyutina, Sofia</au><au>Chervova, Olga</au><au>Maximov, Vladimir</au><au>Nikitenko, Tatiana</au><au>Ryabikov, Andrew</au><au>Voevoda, Mikhail</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>25</volume><issue>9</issue><spage>4850</spage><pages>4850-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>This study investigates the association between epigenetic age acceleration (EAA) derived from DNA methylation and the risk of incident colorectal cancer (CRC). We utilized data from a random population sample of 9,360 individuals (men and women, aged 45-69) from the HAPIEE Study who had been followed up for 16 years. A nested case-control design yielded 35 incident CRC cases and 354 matched controls. Six baseline epigenetic age (EA) measures (Horvath, Hannum, PhenoAge, Skin and Blood (SB), BLUP, and Elastic Net (EN)) were calculated along with their respective EAAs. After adjustment, the odds ratios (ORs) for CRC risk per decile increase in EAA ranged from 1.20 (95% CI: 1.04-1.39) to 1.44 (95% CI: 1.21-1.76) for the Horvath, Hannum, PhenoAge, and BLUP measures. Conversely, the SB and EN EAA measures showed borderline inverse associations with ORs of 0.86-0.87 (95% CI: 0.76-0.99). Tertile analysis reinforced a positive association between CRC risk and four EAA measures (Horvath, Hannum, PhenoAge, and BLUP) and a modest inverse relationship with EN EAA. Our findings from a prospective population-based-case-control study indicate a direct association between incident CRC and four markers of accelerated baseline epigenetic age. In contrast, two markers showed a negative association or no association. These results warrant further exploration in larger cohorts and may have implications for CRC risk assessment and prevention.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38732069</pmid><doi>10.3390/ijms25094850</doi><orcidid>https://orcid.org/0000-0001-9425-413X</orcidid><orcidid>https://orcid.org/0000-0002-1671-9488</orcidid><orcidid>https://orcid.org/0000-0002-7165-4496</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2024-05, Vol.25 (9), p.4850
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_proquest_miscellaneous_3053977756
source MEDLINE; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Age
Aged
Aging
Alcohol use
Biotechnology industry
Cancer
Case-Control Studies
Colorectal cancer
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - genetics
DNA Methylation
Epigenesis, Genetic
Epigenetic inheritance
Epigenetics
Female
Humans
Incidence
Male
Methylation
Middle Aged
Mitochondrial DNA
Mortality
Mutation
Oncology, Experimental
Risk Factors
Skin
Sulindac
Women
title Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood-Based%20Epigenetic%20Age%20Acceleration%20and%20Incident%20Colorectal%20Cancer%20Risk:%20Findings%20from%20a%20Population-Based%20Case-Control%20Study&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Malyutina,%20Sofia&rft.date=2024-05-01&rft.volume=25&rft.issue=9&rft.spage=4850&rft.pages=4850-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25094850&rft_dat=%3Cgale_proqu%3EA793566705%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3053176834&rft_id=info:pmid/38732069&rft_galeid=A793566705&rfr_iscdi=true